Mobile Site ›

Interpretive Handbook

‹ Back to index | Back to list | More information

Test 88539 :
Steroid Sulfatase Deficiency, Xp22.3 Deletion, FISH

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Steroid sulfatase deficiency syndrome is associated with a deletion of the STS gene on the short arm of X chromosome (Xp22.3). The syndrome is an X-linked form of ichthyosis, which is a group of cutaneous disorders characterized by increased or abnormal keratinization. The phenotype is variable, with affected males presenting with dry and scaly skin, sparse hair, and conical teeth.

 

Steroid sulfatase catalyzes the conversion of sulfated steroid precursors to estrogens during pregnancy. Prenatal specimens may be tested in cases where maternal serum screening has identified low or absent levels of unconjugated estriol (UE3). Female relatives of affected males carry the deletion and should be tested if an affected male has been identified.

 

Fluorescence in situ hybridization (FISH) studies are highly specific and do not exclude other chromosome abnormalities. We recommend that patients suspected of having steroid sulfatase deficiency syndrome also have conventional chromosome studies (CMS / Chromosome Analysis, for Congenital Disorders, Blood) performed to rule out other chromosome abnormalities or translocations.

Useful For Suggests clinical disorders or settings where the test may be helpful

As an aid in the diagnosis of steroid sulfatase deficiency syndrome, in conjunction with CMS / Chromosomes Analysis, for Congenital Disorders, Blood

 

Detecting cryptic translocations involving Xp22.3 that are not demonstrated by conventional chromosome studies

Interpretation Provides information to assist in interpretation of the test results

Any individual with a normal signal pattern (1 signal on the X homolog) in each metaphase is considered negative for a deletion in the region tested by this probe.

 

Any patient with a FISH signal pattern indicating loss of the critical region will be reported as having a deletion of the regions tested by this probe.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Because this FISH test is not approved by the FDA, it is important to confirm steroid sulfatase deficiency syndrome diagnoses by other established methods, such as clinical history or physical examination.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

An interpretive report will be provided.

Clinical References Provides recommendations for further in-depth reading of a clinical nature

1. Ballabio A, Zollo M, Carrozzo R, et al: Deletion of the distal short arm of the X chromosome (Xp) in a patient with short stature, chondrodysplasia punctata, and X-linked ichthyosis due to steroid sulfatase deficiency. Am J Med Genet 1991;41:184-187

2. Foote S, Vollrath D, Hilton A, Page DC: The human Y chromosome: overlapping DNA clones spanning the euchromatic region. Science 1992;258:60-66

3. Schnur RE, Trask BJ, van den Engh G, et al: An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry. Am J Hum Genet 1989;45:706-720


Key